SLDB Q1 2025 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena

SLDBSolid Biosciences Inc.

$644M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$407,000

Operating Income

-$40M

Net Income

-$39M

EPS (Diluted)

$-0.59

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$32M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$344M

Total Liabilities

$49M

Stockholders' Equity

$294M

Cash & Equivalents

$211M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$407,000	-$327,000	-24.5%
Operating Income	-$40M	-$27M	-49.1%
Net Income	-$39M	-$24M	-61.6%